Quick note: Taking a shot at MNKD as FDA issued a Complete Response letter regarding the New Drug Application for AFREZZA Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes mellitus for the control of hyperglycemia.
- Buy to open April $10 puts for $1.80.
Good luck!